Treatment with darovasertib resulted in robust ocular tumor shrinkage, lower simulated radiation doses to the eye and meaningful visual gains and reduced long-term risk of blindness for patients in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback